Response to M. tuberculosis selected RD1 peptides in Ugandan HIV-infected patients with smear positive pulmonary tuberculosis Source: Annual Congress 2008 - Interferon-gamma release assay tests for diagnosing tuberculosis infection and disease Year: 2008
The responses of multiple cytokines following incubation of whole blood from TB patients, latently infected individuals, and controls with the TB antigens ESAT-6, CFP-10, and TB7.7 Source: Annual Congress 2012 - Tuberculosis and immunologic assays Year: 2012
Characterization of the HBHA response in TB patients with or without HIV infection. Source: International Congress 2017 – Human susceptibility to tuberculosis Year: 2017
Response to Rv2628 latency antigen associates with cured tuberculosis and remote infection Source: Eur Respir J 2010; 36: 135-142 Year: 2010
Deficient in silico selection of mycobacterium tuberculosis (MTB) epitopes in tuberculosis (TB) patients Source: Eur Respir J 2006; 28: Suppl. 50, 801s Year: 2006
Contribution of a whole blood IFN-gamma release assay for diagnosis of M. tuberculosis infection in BCG-vaccinated children Source: Annual Congress 2008 - New tests and methods to diagnose tuberculosis infection and disease and to monitor treatment Year: 2008
LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement Source: Eur Respir J 2009; 33: 956-973 Year: 2009
Isoniazid prophylaxis differently modulates T-cell responses to RD1-epitopes in contacts recently exposed to mycobacterium tuberculosis: a pilot study Source: Eur Respir J 2007; 30: Suppl. 51, 753s Year: 2007
Effect of prophylaxis on responses for ESAT-6/CFP-10 in whole blood IFN-g test Source: Annual Congress 2005 - Genetics and immunobiology of tuberculosis Year: 2005
IgG-mediated humoral immune response against different mycobacterial antigens in tuberculosis (TB) and mycobacterial infections other than tuberculosis (MOTT) Source: Eur Respir J 2001; 18: Suppl. 33, 307s Year: 2001
Comparison of T-cell interferon-γ release assay to mycobacterium tuberculosis-specific antigens in patients with active and latent tuberculosis Source: Annual Congress 2009 - Tuberculosis contact screening Year: 2009
Comparison between the antigen-specific interferon-gamma assay and the tuberculin skin testing for the detection of tuberculosis infection among BCG vaccinated schoolers at risk for tuberculosis exposure Source: Annual Congress 2007 - Gamma-interferon-based tests to diagnose tuberculosis infection and disease Year: 2007
Evaluation of a IFN-γ test using Mycobacterium tuberculosis -specific antigens for diagnosis of active tuberculosis Source: Eur Respir J 2006; 28: Suppl. 50, 142s Year: 2006
Design of immunogenic multiepitopic mycobacterium tuberculosis peptides from genes selected using in vitro models of mycobacterial macrophage infection Source: Eur Respir J 2007; 30: Suppl. 51, 493s Year: 2007
In vitro immune response to Mycobacterium tuberculosis antigensSource: Eur Respir J 2005; 26: Suppl. 49, 22s Year: 2005
IFN-gamma production in response to RD1 assays correlate with TST size and with the frequency of exposure to the index case in contacts recently exposed to mycobacterium tuberculosis Source: Annual Congress 2007 - New methods to diagnose tuberculosis infection and disease and problems in tuberculosis care Year: 2007
Modulation of QuantiFERON-TB-Gold Plus response in patients with active tuberculosis and latent infection during treatment Source: International Congress 2017 – Migrants and screening Year: 2017
Tuberculosis treatment effect on T-cell interferon-γ responses to Mycobacterium tuberculosis-specific antigens Source: Eur Respir J 2010; 36: 355 Year: 2010
Impact of T-SPOT.TB test to exclude active Mycobacterium tuberculosis complex infection in patients with mycobacterial disease Source: Eur Respir J 2006; 28: Suppl. 50, 139s Year: 2006
ESAT-6/CFP-10 and PPD-stimulated cytokine production in patients with MTB infection Source: Annual Congress 2007 - New methods to diagnose tuberculosis infection and disease Year: 2007